Chemical composition of Homalomena occulta essential oil and molecular docking-ADMET evaluation against antimicrobial targets
PDF

Keywords

Homalomena occulta
P0C0C7
Q8DQF8
4ESW
molecular docking
ADMET

How to Cite

1.
Nguyen VP, Tran HH, Nguyen TTP, Nguyen VBN, Tran QH, Nguyen DC, Nguyen TTH, Phan TQ, Tran NPD, Nguyen TAN. Chemical composition of Homalomena occulta essential oil and molecular docking-ADMET evaluation against antimicrobial targets. hueuni-jns [Internet]. 2026May29 [cited 2026Sep.26];135(1B):37-55. Available from: https://jos.hueuni.edu.vn/index.php/hujos-ns/article/view/8262

Abstract

Homalomena occulta (H. occulta) essential oil was obtained via steam distillation, and its chemical composition was characterised using gas chromatography-mass spectrometry (GC-MS) analysis. A total of 43 compounds, predominantly oxygenated monoterpenes with linalool (40.35%), terpinen-4-ol (8.54%), and a-terpineol (3.05%) as the most abundant components, were identified. These compounds were evaluated in silico through molecular docking simulations using MOE 2022.10 software against three antimicrobial-related targets associated with pathogenic strains, namely Streptococcus pyogenes (P0C0C7), Streptococcus pneumoniae (Q8DQF8), and Candida albicans (4ESW). Several promising candidates with strong predicted inhibitory potentials were identified and ranked for each target as follows: P0C0C7: 40 (–11.2 kcal.mol–1) > 27 (–11.0 kcal.mol–1) > 4 (–10.9 kcal.mol–1) » 36 (–10.9 kcal.mol–1) > 29 (–10.4 kcal.mol–1); Q8DQF8: 27 (–9.6 kcal.mol–1) > 29 (–9.4 kcal.mol–1) > 25 (–9.3 kcal.mol–1) ≈ 41 (–9.3 kcal.mol–1) > 36 (–9.2 kcal.mol–1); 4ESW 42 (–11.3 kcal.mol–1) > 38 (–10.8 kcal.mol–1) > 21 (–10.7 kcal.mol–1) > 32 (–10.3 kcal.mol–1) » 41 (–10.3 kcal.mol–1). A drug-likeness study based on Lipinski’s rule of five was generally favourable (MW < 500 Da for 43/43 compounds; logP < 5 for 41/43 compounds). The ADMET prediction results suggested good absorption and permeability, along with a low risk of major transporter- and metabolism-related issues. Overall, these findings provide a strong in silico basis, supporting further experimental antimicrobial testing for H. occulta essential oil.

https://doi.org/10.26459/hueunijns.v135i1B.8262
PDF

References

  1. Fisher MC, Alastruey-Izquierdo A, Berman J, Bicanic T, Bignell EM, Bowyer P, et al. Tackling the emerging threat of antifungal resistance to human health. Nature Reviews Microbiology. 2022;20(9):557-71.
  2. Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Aguilar GR, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet. 2022;399(10325):629-55.
  3. Poudel AN, Zhu S, Cooper N, Little P, Tarrant C, Hickman M, et al. The economic burden of antibiotic resistance: A systematic review and meta-analysis. PLOS ONE. 2023;18(5):e0285170.
  4. Mitri EA, Reynolds GK, Copaescu AM, Cox F, Waldron JL, Peter JG, et al. State-of-the-Art Review: Antibiotic Allergy—A Multidisciplinary Approach to Delabeling. Clinical Infectious Diseases. 2025;81(4):e74-e92.
  5. Atanasov AG, Zotchev SB, Dirsch VM, Orhan IE, Banach M, Rollinger JM, et al. Natural products in drug discovery: advances and opportunities. Nature Reviews Drug Discovery. 2021;20(3):200-16.
  6. Swamy MK, Akhtar MS, Sinniah UR. Antimicrobial properties of plant essential oils against human pathogens and their mode of action: an updated review. Evidence-Based Complementary and Alternative Medicine. 2016;2016(1):3012462.
  7. Chouhan S, Sharma K, Guleria S. Antimicrobial activity of some essential oils—present status and future perspectives. Medicines. 2017;4(3):58.
  8. Nazzaro F, Fratianni F, Coppola R, Feo VD. Essential oils and antifungal activity. Pharmaceuticals. 2017;10(4):86.
  9. Man A, Santacroce L, Iacob R, Mare A, Man L. Antimicrobial activity of six essential oils against a group of human pathogens: A comparative study. Pathogens. 2019;8(1):15.
  10. Dam SM, Van HT. Chemical profiles and biological activities of essential oils of Arisaema and Homalomena species (Araceae)–A. Journal of Phytology. 2022;14:41-9.
  11. Ngan TTK, Hien TT, Tien LX, Toan TQ. Chemical compositions and stability of Vietnamese Homalomena occulta essential oil under the influence of storage conditions. Egyptian Journal of Chemistry. 2022;65(7):23-31.
  12. Le Thuy T, Le Lam S, Nguyen Van D, Ho Xuan AV, Nguyen Quang M, Tran Thanh M, et al. In vitro antioxidant activity and content of bioactive compounds from Homalomena occulta. Hue University Journal of Science: Natural Science. 2024;133(1B):79-87.
  13. Troeger C, Forouzanfar M, Rao PC, Khalil I, Brown A, Swartz S, et al. Estimates of the global, regional, and national morbidity, mortality, and etiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet Infectious Diseases. 2017;17(11):1133-61
  14. Havlickova B, Czaika VA, Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses. 2008;51(s4):2-15
  15. Kadioglu A, Weiser JN, Paton JC, Andrew PW. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nature Reviews Microbiology. 2008;6(4):288-301.
  16. Silva-Costa C, Friães A, Ramirez M, Melo-Cristino J. Macrolide-resistant Streptococcus pyogenes: prevalence and treatment strategies. Expert Review of Anti-infective Therapy. 2015;13(5):615-28.
  17. Fiedler T, Köller T, Kreikemeyer B. Streptococcus pyogenes biofilms—formation, biology, and clinical relevance. Front Cell Infect Microbiol. 2015;Volume 5 - 2015.
  18. Garvey MI, Baylay AJ, Wong RL, Piddock LJ V. Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy. 2011;55(1):190-6.
  19. Mayer FL, Wilson D, Hube B. Candida albicans pathogenicity mechanisms. Virulence. 2013;4(2):119-28.
  20. Lai RY, Huang S, Fenwick MK, Hazra A, Zhang Y, Rajashankar K, et al. Thiamin pyrimidine biosynthesis in Candida albicans: a remarkable reaction between histidine and pyridoxal phosphate. Journal of the American Chemical Society. 2012;134(22):9157-9.
  21. Babu TMC, Rajesh SS, Bhaskar BV, Devi S, Rammohan A, Sivaraman T, et al. Molecular docking, molecular dynamics simulation, biological evaluation and 2D QSAR analysis of flavonoids from Syzygium alternifolium as potent anti-Helicobacter pylori agents. RSC Advances. 2017;7(30):18277-92.
  22. Tarasova O, Poroikov V, Veselovsky A. Molecular docking studies of HIV-1 resistance to reverse transcriptase inhibitors: Mini-review. Molecules. 2018;23(5):1233.
  23. Thai K-M, Le D-P, Tran N-V-K, Nguyen T-T-H, Tran T-D, Le M-T. Computational assay of Zanamivir binding affinity with original and mutant influenza neuraminidase 9 using molecular docking. Journal of Theoretical Biology. 2015;385:31-9.
  24. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews. 1997;23(1):3-25.
  25. Pires DEV, Blundell TL, Ascher DB. pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. Journal of Medicinal Chemistry. 2015;58(9):4066-72.
Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Copyright (c) 2026 Array